do-me/EUR-LEX huggingface dataset:
Case T-198/22: Action brought on 18 April 2022 — Ioulia and Irene Tseti Pharmaceutical Laboratories v EUIPO — Arbora & Ausonia (InterMed Pharmaceutical Laboratories eva intima)
Date: 2022-04-18
Institutions: General Court
Subjects: EU trade mark, cosmetic product, dietary product, food supplement, marketing, medical device, pharmaceutical product, polishing and scouring preparations, registered trade mark, trade-mark law








C_2022222EN.01003502.xml










7.6.2022   


EN


Official Journal of the European Union


C 222/35






Action brought on 18 April 2022 — Ioulia and Irene Tseti Pharmaceutical Laboratories v EUIPO — Arbora & Ausonia (InterMed Pharmaceutical Laboratories eva intima)
(Case T-198/22)
(2022/C 222/58)
Language in which the application was lodged: English

Parties


Applicant: Ioulia and Irene Tseti Pharmaceutical Laboratories SA (Athens, Greece) (represented by: C. Chrysanthis, P. Chardalia and A. Vasilogamvrou, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Arbora & Ausonia, SLU (Madrid, Spain)

Details of the proceedings before EUIPO


Applicant of the trade mark at issue: Applicant before the General Court

Trade mark at issue: Application for European Union figurative mark InterMed Pharmaceutical Laboratories eva intima — Application for registration No 18 127 266

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the First Board of Appeal of EUIPO of 1 March 2022 in Case R 1245/2021-1

Form of order sought

The applicant claims that the Court should:






—


annul the contested decision so long as it is appealed on its part;










—


order EUIPO and Arbora & Ausonia SLU, if it becomes intervener, to pay the costs of the applicant.





Plea in law







—


Infringement of Article 8(1)(b) of Council Regulation (EC) No 207/2009.
Case C-262/22 P: Appeal brought on 18 April 2022 by QI, QJ, QL, QM, QN, QP, QQ, QT, QU, QW, QX against the judgment of the General Court (Third Chamber) delivered on 9 February 2022 in Case T-868/16, QI and Others v Commission and ECB
Date: 2022-04-18
Institutions: Court of Justice
Subjects: Eurosystem, Greece, aid for restructuring, fundamental rights, legality, ownership, principle of proportionality, private sector, public debt, securities








C_2022244EN.01002001.xml










27.6.2022   


EN


Official Journal of the European Union


C 244/20






Appeal brought on 18 April 2022 by QI, QJ, QL, QM, QN, QP, QQ, QT, QU, QW, QX against the judgment of the General Court (Third Chamber) delivered on 9 February 2022 in Case T-868/16, QI and Others v Commission and ECB
(Case C-262/22 P)
(2022/C 244/25)
Language of the case: English

Parties


Appellants: QI, QJ, QL, QM, QN, QP, QQ, QT, QU, QW, QX (represented by: S. Pappas, A. Pappas, avocats)

Other parties to the proceedings: European Commission, European Central Bank, Council of the European Union, European Council, QK, QO, QR, QS, QV

Form of order sought

The Appellants claim that the Court should:






—


set aside the judgment under appeal;










—


refer the case back to the General Court;










—


order the defendants to pay their own costs and the costs of the Appellants in the present proceedings.





Pleas in law and main arguments

With the present appeal, the Appellants respectfully request the Court of Justice to review and set aside the appealed judgment, on the basis of two grounds:
First, that the General Court performed an inadequate examination of the third plea of illegality of the application, alleging a sufficiently serious breach of the right to property guaranteed by Article 17(1) of the Charter. In turn, this improper examination resulted in the misapplication and infringement of the Appellants’ right to property.
Second, that the General Court infringed the principle of proportionality.
Case T-197/22: Action brought on 18 April 2022 — Ioulia and Irene Tseti Pharmaceutical Laboratories v EUIPO — Arbora & Ausonia (InterMed Pharmaceutical Laboratories eva intima)
Date: 2022-04-18
Institutions: General Court
Subjects: EU trade mark, cosmetic product, dietary product, food supplement, marketing, medical device, pharmaceutical product, polishing and scouring preparations, registered trade mark, trade-mark law








C_2022222EN.01003501.xml










7.6.2022   


EN


Official Journal of the European Union


C 222/35






Action brought on 18 April 2022 — Ioulia and Irene Tseti Pharmaceutical Laboratories v EUIPO — Arbora & Ausonia (InterMed Pharmaceutical Laboratories eva intima)
(Case T-197/22)
(2022/C 222/57)
Language in which the application was lodged: English

Parties


Applicant: Ioulia and Irene Tseti Pharmaceutical Laboratories SA (Athens, Greece) (represented by: C. Chrysanthis, P. Chardalia and A. Vasilogamvrou, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Arbora & Ausonia, SLU (Madrid, Spain)

Details of the proceedings before EUIPO


Applicant of the trade mark at issue: Applicant before the General Court

Trade mark at issue: Application for European Union figurative mark InterMed Pharmaceutical Laboratories eva intima — Application for registration No 18 127 265

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the First Board of Appeal of EUIPO of 1 March 2022 in Case R 1244/2021-1

Form of order sought

The applicant claims that the Court should:






—


annul the contested decision so long as it is appealed on its part;










—


order EUIPO and ARBORA & AUSONIA, SLU, if it becomes intervener, to pay the costs of the applicant.





Plea in law







—


Infringement of Article 8(1)(b) of Council Regulation (EC) No 207/2009.